Moteur de recherche d’entreprises européennes
Financement britannique (580 335 £) : Conception numérique de produits pharmaceutiques Ukri 01/06/2014 Recherche et innovation du Royaume-Uni, Royaume Uni
Vue d’ensemble
Texte
Conception numérique de produits pharmaceutiques
| Abstract | This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and predict processing and product performance. It is anticipated that successful outcomes of digital design of drug formulations as envisaged in this proposal via the creation of “Design Space Explorer” will provide unparalleled improvements in reliability, quality and manufacturing processes of pharmaceutical products leading to greater trust by regulatory agencies and by society. Furthermore it is anticipated that a successful outcome to the proposed project has potential to significantly decrease the costs and times associated with the development of new medicines whilst also reducing, refining and and at times removing the need for some clinical studies in patients and healthy volunteers. |
| Category | Collaborative R&D |
| Reference | 101720 |
| Status | Closed |
| Funded period start | 01/06/2014 |
| Funded period end | 31/05/2016 |
| Funded value | £580 335,00 |
| Source | https://gtr.ukri.org/projects?ref=101720 |
Participating Organisations
| SIEMENS PROCESS SYSTEMS ENGINEERING LIMITED |
£443 597,00 |
| GLAXOSMITHKLINE SERVICES UNLIMITED |
£30 204,00 |
| BRITEST LIMITED |
£75 298,00 |
| ASTRAZENECA UK LIMITED |
£31 236,00 |
| PFIZER LIMITED |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Siemens Process Systems Engineering Ltd., Farnborough, Royaume Uni.